Maple Aviation GmbH

Founded in 2022 in Germany, Maple Aviation GmbH specializes in designing and operating autonomous cargo drones for medical logistics, enhancing the efficiency of critical supply delivery. Maple Aviation GmbH focuses on providing innovative logistics solutions through its autonomous drone technology. The company was founded in 2022 in Germany and has since completed its first funding round. On June 25, 2026, the company raised EUR 4 million in a seed funding round, co-led by Bayern Kapital and ES Kapital.

The funding was part of a larger EUR 4 million seed and grant round. Christoph Busch is the founder and CEO of Maple Aviation GmbH. Maple Aviation specializes in the design and operation of autonomous cargo drones specifically tailored for medical logistics. Their flagship offering, the Maple Octave delivery system, is fully certified and emission-free, engineered to meet the stringent safety standards required by healthcare providers.

The drones facilitate the rapid transport of critical medical cargo, such as blood samples, laboratory specimens, pharmaceuticals, and tissue, effectively reducing delivery times from hours to mere minutes. The service targets hospitals, laboratories, and healthcare networks, including notable clients such as LMU Klinikum and the European Space Agency. With capabilities extending to densely populated urban areas, the drones are operational in various markets across Europe, significantly enhancing the efficiency of medical logistics. Maple Aviation generates revenue through a per-transport pricing structure, allowing clients to pay solely for the deliveries they utilize without the need for upfront investment in drone technology or infrastructure.

Transactions typically occur through direct partnerships with healthcare providers, where facilities can integrate a simple window adapter to receive deliveries. Clients leverage the Maple app to request drone services, and the autonomous drones handle the cargo pickup and delivery seamlessly. This model caters to the urgent needs of the healthcare sector, facilitating up to 10 kg of medical cargo per flight over distances of up to 70 km at speeds of 90 km/h. The operational framework underscores a B2B approach, emphasizing partnerships over traditional retail channels, and aligns with the company’s mission to streamline medical logistics through innovative technology.

The company aims to introduce new products designed to enhance their service offerings. They also plan to expand into new markets across Europe, with specific regions targeted for growth by 2027. This funding will support their strategic initiatives as they aim to improve and broaden their operational capabilities.